ID: ALA5204304

Max Phase: Preclinical

Molecular Formula: C34H41N5O6

Molecular Weight: 615.73

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)C(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](n2ccc3ccccc32)NC1=O

Standard InChI:  InChI=1S/C34H41N5O6/c1-22(40)29(41)17-7-3-6-14-25-31(42)37-30(38-20-18-24-13-8-9-15-27(24)38)33(44)36-26(21-23-11-4-2-5-12-23)34(45)39-19-10-16-28(39)32(43)35-25/h2,4-5,8-9,11-13,15,18,20,22,25-26,28,30,40H,3,6-7,10,14,16-17,19,21H2,1H3,(H,35,43)(H,36,44)(H,37,42)/t22-,25+,26+,28-,30+/m1/s1

Standard InChI Key:  ZTOPZCOUZQXWSK-RLQIRPRCSA-N

Associated Targets(Human)

Histone deacetylase 4 2328 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 615.73Molecular Weight (Monoisotopic): 615.3057AlogP: 2.37#Rotatable Bonds: 10
Polar Surface Area: 149.84Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.34CX Basic pKa: CX LogP: 2.80CX LogD: 2.80
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.26Np Likeness Score: 0.47

References

1. Qiu X, Zhu L, Wang H, Tan Y, Yang Z, Yang L, Wan L..  (2021)  From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.,  52  [PMID:34826681] [10.1016/j.bmc.2021.116510]

Source